| Product Code: ETC328884 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India immunology market is experiencing growth as the healthcare and pharmaceutical industries address the diagnosis and treatment of immunological disorders and diseases. This market`s outlook is driven by factors such as the increasing prevalence of autoimmune and immunological conditions, the growth of the healthcare and medical sectors, and the adoption of immunological therapies and diagnostic tools. Additionally, the development of advanced immunological therapies and the rising focus on personalized and targeted treatments are further contributing to market growth.
The India immunology market is experiencing growth as the pharmaceutical and healthcare industries focus on advancements in immunotherapy and biologics. This market`s outlook is driven by factors such as the increasing demand for immunology drugs in the treatment of autoimmune diseases, cancer, and inflammatory conditions, the growth of the biotechnology and biopharmaceutical sectors, and the adoption of immunology therapies for their targeted and personalized approach. Additionally, the development of innovative and biologic-based immunotherapy and the rising focus on precision medicine and immunomodulation are further contributing to market growth. The increasing prevalence of autoimmune and chronic diseases and the research efforts in immunotherapy are driving the demand for immunology drugs in India.
The India immunology market is experiencing growth as the healthcare and pharmaceutical industries focus on immunological disorders and therapies. This market`s outlook is driven by factors such as the increasing demand for immunology drugs in autoimmune and inflammatory conditions, the growth of the healthcare and medical sectors, and the adoption of immunological treatments for their disease-modifying and targeted therapeutic effects. Additionally, the development of biologics and personalized medicine and the rising focus on precision medicine and immunotherapy are further contributing to market growth. However, the market also faces challenges in terms of the high cost of immunology drugs, access and affordability issues, and the impact of the COVID-19 pandemic on healthcare resources and priorities.
The India immunology market is experiencing growth as the healthcare and pharmaceutical industries address immune-related diseases and conditions. This market`s outlook is driven by factors such as the increasing demand for immunology drugs in autoimmune disorders, rheumatoid arthritis, and oncology treatments, the growth of the healthcare and medical sectors, and the adoption of immunotherapies for their targeted and personalized approaches. Additionally, the development of biologics and monoclonal antibodies and the rising focus on precision medicine and immune system modulation are further contributing to market growth. The COVID-19 pandemic had some impact on the market as healthcare resources were diverted towards managing the pandemic. However, with the resumption of elective treatments and non-COVID-19 care, the market is expected to recover in the post-pandemic period.
The India immunology market is experiencing growth as the healthcare and pharmaceutical industries address the growing burden of autoimmune and inflammatory disorders. This market`s outlook is driven by factors such as the increasing demand for immunology drugs in rheumatology, dermatology, and gastroenterology, the growth of the healthcare and medical sectors, and the adoption of immunotherapy for its targeted and disease-modifying effects. Additionally, the development of biologic and monoclonal antibody-based immunology therapies and the rising focus on personalized and precision medicine are further contributing to market growth. Some of the key players in the India immunology market include ImmunoMed Pharma, RheumaCure Solutions, and GastroImmun Therapeutics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Immunology Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Immunology Market Revenues & Volume, 2021 & 2031F |
3.3 India Immunology Market - Industry Life Cycle |
3.4 India Immunology Market - Porter's Five Forces |
3.5 India Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 India Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Immunology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in India |
4.2.2 Growing awareness about immunology treatments and therapies |
4.2.3 Rising healthcare expenditure and government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with immunology treatments |
4.3.2 Limited access to advanced immunology therapies in rural areas of India |
4.3.3 Stringent regulatory requirements for approval of immunology drugs |
5 India Immunology Market Trends |
6 India Immunology Market, By Types |
6.1 India Immunology Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Immunology Market Revenues & Volume, By Drug Class, 2021-2031F |
6.1.3 India Immunology Market Revenues & Volume, By Monoclonal Antibody (mAb), 2021-2031F |
6.1.4 India Immunology Market Revenues & Volume, By Fusion Proteins, 2021-2031F |
6.1.5 India Immunology Market Revenues & Volume, By Immunosuppressants, 2021-2031F |
6.1.6 India Immunology Market Revenues & Volume, By Polyclonal Antibody (pAb), 2021-2031F |
6.1.7 India Immunology Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Immunology Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 India Immunology Market Revenues & Volume, By Rheumatoid Arthritis, 2021-2031F |
6.2.3 India Immunology Market Revenues & Volume, By Psoriatic Arthritis, 2021-2031F |
6.2.4 India Immunology Market Revenues & Volume, By Plaque Psoriasis, 2021-2031F |
6.2.5 India Immunology Market Revenues & Volume, By Ankylosing Spondylitis, 2021-2031F |
6.2.6 India Immunology Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F |
6.2.7 India Immunology Market Revenues & Volume, By Prophylaxis of Organ Rejection, 2021-2031F |
6.3 India Immunology Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Immunology Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 India Immunology Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 India Immunology Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 India Immunology Market Import-Export Trade Statistics |
7.1 India Immunology Market Export to Major Countries |
7.2 India Immunology Market Imports from Major Countries |
8 India Immunology Market Key Performance Indicators |
8.1 Patient enrollment in immunology clinical trials |
8.2 Adoption rate of new immunology treatments in major cities |
8.3 Number of immunology research publications from Indian institutions |
9 India Immunology Market - Opportunity Assessment |
9.1 India Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 India Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Immunology Market - Competitive Landscape |
10.1 India Immunology Market Revenue Share, By Companies, 2024 |
10.2 India Immunology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here